The effect of endotoxin on functional parameters of mammary CID-9 cells.
The effect of endotoxin on mammary CID-9 cells, which differentiate in culture and express beta-casein, was investigated. Cells in culture supplemented with lactogenic hormones and dripped with EMS-Matrix (EMS-drip), were treated daily with endotoxin (0.5-500 microg/ml). Endotoxin at concentrations of less or equal to 10 microg/ml did not affect cell growth and viability up to 5 days post endotoxin treatment. Endotoxin (0.01-10 microg/ml) was added to the culture medium, upon confluence, and functional parameters were examined within 48 h post endotoxin treatment. Nuclear factor-kappaB (NF-kappaB) (p52) increased in nuclear extracts from endotoxin-stimulated cells within 1 h of treatment, while beta-casein mRNA and protein expression decreased in a concentration-dependent manner at 24 and 48 h post treatment. Zymography showed that the 72 and 92 kDa gelatinase activity increased in cells at 24 and 48 h post endotoxin treatment at 10 and 50 microg/ml. At the latter concentration, the active form of 72 kDa gelatinase was induced at 48 h. Interleukin-6 and tumor necrosis factor-alpha levels increased at 1-3 h post endotoxin treatment and peaked at 6 h in cells on plastic and EHS-drip. Nerve growth factor (NGF) levels increased in control and endotoxin-treated cells in a time-dependent manner, and endotoxin increased NGF levels in culture at 6 and 9 h post endotoxin treatment. This study shows that endotoxin activated NF-kappaB, suppressed beta-casein expression and upregulated gelatinases, cytokines and NGF. This model could be used to investigate the role of mammary cells in initiating and propagating inflammation and to test candidate molecules for potential anti-inflammatory properties.
Safieh-Garabedian
B
B
Department of Biology, Faculty of Arts and Sciences, PO Box 11-0236, American University of Beirut, Beirut, Lebanon.
Mouneimne
G M
GM
El-Jouni
W
W
Khattar
M
M
Talhouk
R
R
D000818:Animals; D015153:Blotting, Western / Q000379:methods; D002364:Caseins / Q000378:metabolism; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay / Q000379:methods; D004731:Endotoxins / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D018093:Gelatinases / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D008413:Mastitis / Q000276:immunology*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D020932:Nerve Growth Factor / Q000378:metabolism
D002364:Caseins; D016207:Cytokines; D004731:Endotoxins; D016328:NF-kappa B; D020932:Nerve Growth Factor; D018093:Gelatinases